Clopidogrel Loading Dose Adjustment According To Platelet Reactivity Monitoring In Patients Carrying The 2c19 2*Loss Of Function Polymorphism

被引：0
|
作者：
Bonello, Laurent, Jr. [1 ]
Armero, Sebastian [1 ]
Camoin-Jau, Laurence [1 ]
Paganelli, Franck [1 ]
机构：
[1] Hop Univ Nord, Marseille, France
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 56卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-4
引用
收藏
页码：B1 / B1
页数：1
相关论文
共 50 条
  • [31] The influence of cytochrome P450 2C19*2 and*17 genotype, diplotype and metabolizer status on platelet reactivity in patients on maintenance clopidogrel therapy
    Gurbei, P. A.
    Tantry, U. S.
    Antonino, M. J.
    Bliden, K. P.
    Pakyz, R. E.
    Shuldiner, A. R.
    EUROPEAN HEART JOURNAL, 2010, 31 : 1016 - 1017
  • [32] THE INFLUENCE OF CYTOCHROME P450 2C19*2 AND*17 GENOTYPE, DIPLOTYPE AND METABOLIZER STATUS ON PLATELET REACTIVITY IN PATIENTS ON MAINTENANCE CLOPIDOGREL THERAPY
    Gurbel, Paul A.
    Tantry, Udaya S.
    Antonino, Mark J.
    Bliden, Kevin P.
    Pakyz, Ruth E.
    Shuldiner, Alan R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [33] CYTOCHROME P450 2C19 POLYMORPHISM AND PLATELET AGGREGATION IN CLOPIDOGREL-TREATED PATIENTS AMONG MALAYSIAN MULTIETHNIC POPULATION
    Tiong, Wen Ni
    Fong, Alan Yean Yip
    Hwang, Siaw San
    Wee, Ching Ching
    Mejin, Melissa
    Ong, Tiong Kiam
    Tiong, Wen Ni
    HEART, 2012, 98 : E270 - E270
  • [34] Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients
    Olie, Renske H.
    Hensgens, Rachelle R. K.
    Wijnen, Petal A. H. M.
    Veenstra, Leo F.
    de Greef, Bianca T. A.
    Vries, Minka J. A.
    van der Meijden, Paola E. J.
    ten Berg, Jurrien M.
    ten Cate, Hugo
    Bekers, Otto
    Henskens, Yvonne M. C.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [35] Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade
    Bonello, Laurent
    Camoin-Jau, Laurence
    Mancini, Julien
    Bessereau, Jacques
    Grosdidier, Charlotte
    Alessi, Marie-Christine
    Ostorero, Michel
    Dignat-George, Francoise
    Paganelli, Franck
    THROMBOSIS RESEARCH, 2012, 130 (01) : 70 - 74
  • [36] Platelet Inhibition by Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel In Patients with Acute Myocardial Infarction According to Cytochrome P450 2C19 Genotype
    Kim, In-Sux
    Jeong, Young-Hoon
    Kim, Arum
    Lee, Gyeong-Won
    BLOOD, 2010, 116 (21) : 1361 - 1361
  • [37] Cytochrome P450 2C19 polymorphism and clopidogrel after MI Reply
    Collet, J. P.
    Hulot, J. S.
    Montalescot, G.
    LANCET, 2009, 373 (9670): : 1172 - 1173
  • [38] Platelet Inhibition by Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel in Patients With Acute Myocardial Infarction According to Cytochrome P450 2C19 Genotype
    Kim, In-Suk
    Jeong, Young-Hoon
    Park, Yongwhi
    Park, Ki-Soo
    Yun, Seong-Eun
    Park, Jeong-Rang
    Hwang, Seok-Jae
    Koh, Eun-Ha
    Kwak, Choong Hwan
    Hwang, Jin-Yong
    Kim, Sunjoo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (04) : 381 - 391
  • [39] Inverse effect of cytochrome P450 2C19 polymorphisms on platelet response in clopidogrel low-responsive patient receiving higher dose adjustment
    Tunthong, R.
    Vathesatogkit, P.
    Yamwong, S.
    Sukasem, C.
    Chantratita, W.
    Angchaisuksiri, P.
    Chuncharunee, S.
    Sura, T.
    Boonbaichaiyapruck, S.
    Sritara, P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 969 - 969
  • [40] First comparison of platelet inhibition by cilostazol vs. clopidogrel in patients with cytochrome 2C19 loss-of-function allele: results of the ACCEL-switch study
    Jeong, Y-H
    Park, Y.
    Kim, I-S
    Yun, S-E
    Jung, K. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 76 - 76
12345